Il dossier in valutazione allAgenzia Europea del Farmaco (EMA), ma con tempi pi lunghi rispetto al semaglutide orale
Tirzepatide can be used by itself, or in combination with other medications
Driven by high-profile trial data, the FDA is evaluating expanded indications, higher-dose formats, and oral daily pills
AnithaANakamuraKThanseemIMatsuzakiHMiyachiTTsujiiMet al
The most common side effect is mild nausea, particularly during the first 12 weeks or after dose increases, which typically resolves within days
The research cannot account for whether the people who continue using GLP-1 drugs are systematically different in personality, impulse control, or circumstances from those who stopped, which could produce the apparent association without any pharmacological mechanism